Paul Sekhri
President at vTv Therapeutics
New York, New York
Overview
Work Experience
Chairman, President and CEO, vTv Therapeutics, Inc.
2022 - Current
Board Member
2024
Smart devices and digital support that connect patients to care, with clinically-proven results
Raised $3,770,000.00 from The Argentum Group.
Board Member
2022
Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides.
Board Member
2021
Spring Science is a software platform that offers image analysis services for researchers.
Chairman Of The Board
2021
Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.
Raised $79,000,000.00 from HBM Healthcare Investments, Cormorant Asset Management, Farallon Capital Management, Highline Capital Management and T. Rowe Price.
Chairman Of The Board
2017
Board Member
2014
Veeva Systems is a provider of cloud-based business solutions for the global life sciences industry.
Raised $7,000,000.00 from Emergence.
Board Member
2019 - 2024
President and CEO
2019 - 2022
eGenesis is revolutionizing the field of xenotransplantation.
Board Director
2018 - 2023
Member of the Audit Committee Member of the Nomination Committee Member of the Innovation Development Committee
Chairman of the Board
2015 - 2023
Education
B.Sc.
1978 - 1981
Bachelor's degree
1979 - 1982